Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Stage Set for Acorda Bounce?
Seeking Alpha
Monday, October 12, 2009 - 11:18am
tags:
Acorda Therapeutics, Biogen Idec
BDSI Insider Selling Was a Blessing for Investors
Seeking Alpha
Monday, October 12, 2009 - 11:16am
tags:
BioDelivery Sciences
Stock-pickers call Gilead, Teva investor-friendly
Fierce Pharma
Monday, October 12, 2009 - 11:15am
tags:
Gilead Sciences, Teva Pharmaceuticals
Drug stocks edge higher; DepoMed sinks on drug data
Marketwatch
Monday, October 12, 2009 - 11:14am
tags:
Depomed, drug stocks
Earnings Preview: Abbott Laboratories
Yahoo/AP
Monday, October 12, 2009 - 11:12am
tags:
earnings, Abbott Laboratories
Becton Receives FDA Approval
Yahoo/AP
Monday, October 12, 2009 - 10:50am
tags:
FDA, Becton Dickinson, Abbott Laboratories, Baxter International
Econo-gloom bypasses pharma earnings
Fierce Pharma
Monday, October 12, 2009 - 9:53am
tags:
earnings, JNJ, Abbott Laboratories, Roche
Why I'm Taking a Foothold in Generex Now
Seeking Alpha
Monday, October 12, 2009 - 9:20am
tags:
Generex, MannKind, Invo Bioscience, NovaDel
DepoMed Trial Disappoints; Shares Plunge
TheStreet.com
Monday, October 12, 2009 - 9:19am
tags:
Depomed, drug trials, Serada, hot flashes, menopause
Santarus licenses GI-disorder drug to Norgine
Marketwatch
Monday, October 12, 2009 - 9:18am
tags:
Norgine, Santarus
Pfizer's Silence on Post-Wyeth Merger Job Cuts, Site Closures Has Everyone on Edge
BNET Pharma
Monday, October 12, 2009 - 9:17am
tags:
Pfizer, Wyeth, M&A, reorganization
Johnson & Johnson makes 4 deals, awaits new product approvals amid slumping sales
Yahoo/AP
Monday, October 12, 2009 - 9:15am
tags:
JNJ, Gilead Sciences, Merck
Health Workers Sue to Void FDA Approval of Swine Flu Vaccine
Bloomberg
Monday, October 12, 2009 - 9:12am
tags:
swine flu, vaccines, H1N1, FDA
Onyx to Buy Proteolix for $276 Million, Gaining a Cancer Drug
Bloomberg
Monday, October 12, 2009 - 9:09am
tags:
cancer, Proteolix, ONYX Pharmaceuticals, M&A
Pfizer Suspends Lung Cancer Study
Forbes
Monday, October 12, 2009 - 9:08am
tags:
Pfizer, lung cancer, figitumumab
Merial invests US $70 million in Nanchang, China
Yahoo
Monday, October 12, 2009 - 9:04am
tags:
Merial, China, animal health
Lupin eyes $200 mn opportunity in US mkt
Indian Express
Sunday, October 11, 2009 - 11:39am
tags:
Lupin
Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug
Medical News Today
Sunday, October 11, 2009 - 11:37am
tags:
Pfizer, AIDS, Selzentry
Glaxo Expands Presence in China
Yahoo/Zacks
Saturday, October 10, 2009 - 12:39pm
tags:
GSK, China
Savient Pharma recovers after analyst upgrade
Yahoo/AP
Saturday, October 10, 2009 - 12:38pm
tags:
Savient, Krystexxa, gout

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.